List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 153 studies with search of: "Lapatinib"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Ductal Carcinoma In Situ (DCIS) Lapatinib Trial
Condition: Breast Cancer
Interventions: Drug: GW572016;   Drug: GW572016;   Drug: GW 572016;   Drug: Placebo
2 Active, not recruiting Pazopanib Plus Lapatinib Compared To Lapatinib Alone In Subjects With Advanced Or Metastatic Breast Cancer
Condition: Metastatic Breast Cancer
Interventions: Drug: pazopanib (GW786034);   Drug: lapatinib (GW572016)
3 Recruiting Pazopanib Plus Lapatinib Compared To Lapatinib Alone In Subjects With Inflammatory Breast Cancer
Condition: Inflammatory Breast Cancer
Interventions: Drug: lapatinib (Tykerb);   Drug: pazopanib (GW786034);   Drug: Pazopanib
4 Withdrawn A Phase I Study Of Oral Topotecan And Lapatinib In Subjects With Advanced Solid Tumors
Condition: Advanced Solid Tumors
Intervention: Drug: oral topotecan (SK&F-104864); lapatinib (GW572016)
5 Completed Effects Of Lapatinib (GW572016) In Patients With Relapsed Adenocarcinoma Of The Esophagus
Condition: Adenocarcinoma
Intervention: Drug: Lapatinib (GW572016) oral tablets
6 Recruiting Neoadjuvant GW572016 to Treat Breast Cancer
Condition: Breast Cancer
Interventions: Drug: GW572016;   Drug: lapatinib
7 Completed Paclitaxel With / Without GW572016 (Lapatinib) As First Line Therapy For Women With Advanced Or Metastatic Breast Cancer
Condition: Metastatic Breast Cancer
Interventions: Drug: Paclitaxel;   Drug: GW572016 (Lapatinib)
8 Active, not recruiting Tykerb Evaluation After Chemotherapy (TEACH): Lapatinib Versus Placebo In Women With Early-Stage Breast Cancer
Condition: Breast Cancer
Intervention: Drug: lapatinib (GW572016)
9 Not yet recruiting A Study to Examine the Effects of Esomeprazole on the Pharmacokinetics of Orally Administered Lapatinib in Subjects With Metastatic ErbB2 Positive Breast Cancer
Condition: Advanced or Metastatic ErbB2-Overexpressing Breast Cancer
Interventions: Drug: lapatinib;   Drug: lapatinib plus esomeprazole
10 Completed A Study Of Oral GW572016 In Advanced Or Metastatic Non-Small Cell Lung Cancer
Condition: Non-Small-Cell Lung Cancer
Intervention: Drug: GW572016 (lapatinib)
11 Active, not recruiting Pazopanib Plus Lapatinib Compared to Lapatinib Alone and Pazopanib Alone In Subjects With Metastatic Cervical Cancer
Condition: Metastatic Cervical Cancer
Intervention: Drug: pazopanib (GW786034), lapatinib (GW572016)
12 Recruiting LOGiC - Lapatinib Optimization Study in ErbB2 (HER2) Positive Gastric Cancer: A Phase III Global, Blinded Study Designed to Evaluate Clinical Endpoints and Safety of Chemotherapy Plus Lapatinib
Conditions: ErbB2 (HER2) Amplified Gastric;   Esophageal;   or Gastro-Esophageal Junction Adenocarcinoma That is Unresectable Due to Locally Advanced Metastatic, or Locally Recurrent Disease.
Intervention: Drug: Lapatinib
13 Active, not recruiting Capecitabine (XELODA) With Or Without Lapatinib(GW572016)For Women With Refractory Advanced or Metastatic Breast Cancer
Condition: Breast Cancer
Interventions: Drug: capecitabine;   Drug: lapatinib (GW572016)
14 Not yet recruiting Lapatinib and Capecitabine for Second Line Treatment of Pancreas Cancer
Condition: Pancreas Cancer
Intervention: Drug: Lapatinib and Capecitabine
15 Recruiting Phase II Lapatinib Plus Nab-Paclitaxel As First And Second Line Therapy In her2+ MBC
Conditions: Metastatic Breast Cancer;   First or Second Line Therapy
Intervention: Drug: Lapatinib/nab-Paclitaxel
16 Not yet recruiting Bevacizumab and Lapatinib in Children With Recurrent or Refractory Ependymoma
Conditions: Brain Cancer;   Pediatric Cancers
Interventions: Drug: Bevacizumab;   Drug: Lapatinib
17 Recruiting A Study to Evaluate the Efficacy of Lapatinib in the Blood of Women With Breast Cancer
Condition: Metastatic Breast Cancer
Intervention: Drug: Lapatinib
18 Not yet recruiting Concentration and Activity of Lapatinib in Vestibular Schwannomas
Conditions: Vestibular Schwannoma;   NF2;   Neurofibromatosis 2;   Acoustic Neuroma;   Auditory Tumor
Intervention: Drug: lapatinib
19 Recruiting Neo ALTTO (Neoadjuvant Lapatinib and/or Trastuzumab Treatment Optimisation) Study
Condition: Early Breast Cancer
Intervention: Drug: Lapatinib
20 Recruiting Phase I Study of Ixabepilone + Lapatinib +/- Capecitabine to Treat HER2 Positive Locally Advanced or Metastatic Breast Cancer
Conditions: Locally Advanced Breast Cancer;   Metastatic Breast Cancer
Interventions: Drug: Ixabepilone + lapatinib;   Drug: Ixabepilone + lapatinib + capecitabine

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services